Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.

Clinical studies have reported that the nicotinic receptor agonist varenicline improves balance and coordination in patients with several types of ataxia, but confirmation in an animal model has not been demonstrated. This study investigated whether varenicline and nicotine could attenuate the ataxia induced in rats following destruction of the olivocerebellar pathway by the neurotoxin 3-acetylpyridine (3-AP). The administration of 3-AP (70 mg/kg followed by 300 mg niacinamide/kg; i.p.) led to an 85% loss of inferior olivary neurons within one week without evidence of recovery, and was accompanied by a 72% decrease in rotorod activity, a 3-fold increase in the time to traverse a stationary beam, a 19% decrease in velocity and 31% decrease in distance moved in the open field, and alterations in gait parameters, with a 19% increase in hindpaw stride width. The daily administration of nicotine (0.33 mg free base/kg) for one week improved rotorod performance by 50% and normalized the increased hindpaw stride width, effects that were prevented by the daily preadministration of the nicotinic antagonist mecamylamine (0.8 mg free base/kg). Varenicline (1 and 3 mg free base/kg daily) also improved rotorod performance by approximately 50% following one week of administration, and although it did not alter the time to traverse the beam, it did improve the ability to maintain balance on the beam. Neither varenicline nor nicotine, at doses that improved balance, affected impaired locomotor activity in the open field. Results provide evidence that nicotinic agonists are of benefit for alleviating some of the behavioral deficits in olivocerebellar ataxia and warrant further studies to elucidate the specific mechanism(s) involved.

Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation.

Eosinophilic leukocytes have been implicated as primary effector cells in inflammatory and allergic diseases. When activated by cytokines, human eosinophils secrete and produce a variety of proinflammatory or tissue damaging substances. Although well known for their chemoattractant effects, little is known about the precise contribution of the eosinophil-selective chemokines, eotaxin, eotaxin-2, and eotaxin-3 to the effector functions of eosinophils. This forms the central focus of these investigations for which clone 15-HL-60 human eosinophilic cells were used as the in vitro model. Investigation results suggest that all three subtypes of eotaxin directly stimulate eosinophil superoxide anion generation that is inhibited by neutralizing eotaxin antibody or pretreatment of cells with the receptor antibody anti-CCR3. Pretreatment or co-treatment with each of the eotaxins augmented phorbol myristate-induced superoxide generation. Concentration-dependent degranulation of eosinophil peroxidase was noted for all three chemokines, and potentiation of calcium ionophore-induced degranulation was observed with eotaxin pretreatments. Results of interleukin-5 pretreatment studies suggest that the eotaxin chemokines may act cooperatively to enhance effector functions of eosinophils. Collectively, the present studies have advanced knowledge of the eotaxin family of chemokines to include eosinophil priming and modulation of eosinophil activation and secretion effector functions.

Steroid hormones modulate expression of cytochrome P450 enzymes in male hamster reproductive tract and leiomyosarcomas.

Syrian hamsters treated with estrogen and androgen for 8 months develop leiomyosarcomas in the vas deferens. Metabolism of estrogen by cytochrome P450s (CYPs) produces catechols and reactive oxygen species, and may contribute to tumor formation. To examine this issue, male hamsters were treated with 17 beta-estradiol (E2), testosterone propionate (TP) or both hormones. Reproductive tract tissues from control and treated animals were immunostained with antibodies specific for four CYP enzymes (1A1, 1A2, 1B1 and 3A1/2). Immunoreactive CYP1A1 was not found in the reproductive tract of control or treated animals. In untreated hamsters, CYP1A2 was detected only in principal cells of the caput epididymis. TP alone had no effect, but treatment with E2 induced expression of CYP1A2 in columnar epithelial cells throughout the epididymis and lining of the vas deferens. Treatment with E2 + TP blocked the induction of CYP1A2 seen in surface epithelial cells treated with E2 alone, but not the constitutive expression of this enzyme. Instead, simultaneous exposure to both hormones induced CYP1A2 in basal cells of the epididymis and vas deferens. CYP3A1/2 was not detected in the reproductive tract of control or TP-treated males, but immunostaining was induced in the inner layer of vas deferens smooth muscle by E2, and in all smooth muscle layers by dual hormone treatment. In controls, CYP1B1 was present in smooth muscle lining the epididymis and surrounding the vas deferens and dual hormone treatment increased staining intensity for CYP1B1 in these cells. Immunoreactive CYP1A2 was not detectable in leiomyosarcomas but the enzyme was present in both columnar and basal cells of the vas deferens epithelium adjacent to the tumors. In contrast, tumor cells showed heterogeneous expression of both CYP1B1 and CYP3A1/2. The relationships between hormone treatment, differential CYP expression and tumor formation strengthen our hypothesis that metabolism of estrogen is an important element in this model of hormonal carcinogenesis.

Exogenous 17beta-estradiol blocks alpha and mu but not pi class glutathione S-transferase immunoreactivity in epithelium of Syrian hamster vas deferens.

Members of the glutathione S-transferase (GST) family of detoxification enzymes play a role in chemotherapy resistance in certain cancers but have not been directly implicated as agents whose absence may predispose tissues to hormonally induced tumorigenesis. Here we report the development of a polyclonal antiserum to a hamster mu class GST, and immunohistochemical analysis of alpha, mu, and pi class GSTs to study the effects of hormone treatment on their expression in reproductive tract tissues of male golden Syrian hamsters. These animals develop leiomyosarcomas in the vas deferens after treatment with testosterone propionate (TP) and 17beta-estradiol (E2). High levels of all three GST classes were detected throughout the reproductive tract epithelium of control animals. In 100% of the experimental animals, 4 weeks of treatment either with E2 alone, or with E2 plus TP promoted a complete loss of immunostaining for alpha and mu class GSTs, but not for pi class GSTs, only in the epithelial lining of the vas deferens. In contrast, treatment with TP alone resulted in moderate hyperplasia of smooth muscle in the proximal vas deferens, with no cellular atypia and no changes in immunoreactivity of any of the GST classes. The consistent and site-specific nature of these results strongly suggests a functional role for GSTs in hormonally induced carcinogenic process. (J Histochem Cytochem 47:91-98, 1999)

Glutathione S-transferase in hormonal carcinogenesis.

Treatment with testosterone propionate (TP) and diethylstilbestrol (DES) or TP and estradiol (E2) for 8-9 months causes development of leiomyosarcomas in the vas deferens or uterus of Golden Syrian hamsters at a frequency of 100%. In males, treatment with estrogens alone results in renal tumors, fatal within 6 months. No leiomyosarcomas have been detected after treatment with estrogens alone, perhaps due to this high mortality rate. In tissue culture, treatment with the glucocorticoid (GC) triamcinolone acetonide (TA) results in an increased expression of a mu-class glutathione S-transferase (GST) (hGSTYBX). We have characterized this induction as a secondary response, i.e. requiring new protein synthesis. Here we describe homologies to known transcription factor-binding sites in the hGSTYBX promoter which may be involved in the induction event. hGSTYBX is a member of a superfamily of detoxification enzymes, induced by genotoxic compounds and reactive oxygen species (ROS). We also describe the effects of several known inducers of other GST family members on hGSTYBX. While implicated in many chemotherapeutic-resistant tumors, GST enzymes have not yet been characterized as a functional agent in hormonal carcinogenesis. This latter possibility is the focus of our investigations. To study the effects of hormone treatment on GST levels in vivo, we have developed a polyclonal antibody to hGSTYBX, and conducted immunohistochemistry on tissues from control and treated animals. Treatment with TP and E2 causes a loss of hGSTYBX expression in the epithelium of the vas deferens. We hypothesize that the loss of this protective enzyme leaves the cells vulnerable to the genotoxic effects of estrogen or estrogenic metabolites.

A photoionization study of the ion-neutral complexes CH3CH (+)CH 3 (·) CH 2CH 3] and CH 3CH 2CH (+)CH 3 (·) CH 3 in the gas phase: Formation, H-transfer and C-C bond formation between partners, and channeling of energy into dissociation.

Photoionization mass spectrometry was used to investigate the dynamics of ion-neutral complex-mediated dissociations of the n-pentane ion (1). Reinterpretation of previous data demonstrates that a fraction of ions 1 isomerizes to the 2-methylbutane ion (2) through the complex CH3CH(+)CH 3 (·) CH2CH3 (3), but not through CH3CH(+)CH2CH 3 (·) CH3 (4). The appearance energy for C3Hin 7 (+) formation from 1 is 66 kJ mol(-1) below that expected for the formation of n-C3H 7 (+) and just above that expected for formation of i-C3H 7 (+) . This demonstrates that the H shift that isomerizes C3H 7 (+) is synchronized with bond cleavage at the threshold for dissociation to that product. It is suggested that ions that contain n-alkyl chains generally dissociate directly to more stable rearranged carbenium ions. Ethane elimination from 3 is estimated to be about seven times more frequent than is C-C bond formation between the partners in that complex to form 2, which demonstrates a substantial preference in 3 for H abstraction over C-C bond formation. In 1 → CH3CH(+)CH2CH3 + CH3 by direct cleavage of the C1-C2 bond, the fragments part rapidly enough to prevent any reaction between them. However, 1 → 2 → 4 → C4H 8 (+) + CH4 occurs in this same energy range. Thus some of the potential energy made available by the isomerization of n-C4H9 in 1 is specifically channeled into the coordinate for dissociation. In contrast, analogous formation of 3 by 1 → 3 is predominantly followed by reaction between the electrostatically bound partners.

Ab initio characterization of ring-opening H-transfer in ionized cyclopentanone: Similarity to ion-neutral complex-mediated alkane eliminations.

Ab initio procedures were used to characterize the transition states for α-cleavage and subsequent H-transfer starting with ionized cyclopentanone (1). The objective was to determine whether the parts of the ion disconnected by the bond cleavage remain in close association through the H-transfer. The transition state for C-C bond cleavage is close in energy to the resulting distonic ion, which is a stable species, and far in geometry from any transition state involving H-transfer. We find no evidence for any concertedness or "quasiconcertedness" in this reaction. Ring-opening H-transfer in 1 and ion-neutral complex-mediated alkane eliminations are compared.

Preference for an ion-neutral complex-mediated pathway over a five-membered-ring H shift in the isomerization of CH3O (+)HCH 2CH 2 (·) to CH 3CH 2CH 2OH (+·) by Ab initio theory.

Ab initio theory is used to explore whether the path from CH3OH(+)CH2CH 2 (·) (1) to CH3CH2CH2OH(+·) (5) goes by way of a conventional 1,4-H shift to form ·CH2OH(+)CH2CH3 (2), or via the ion-neutral complex-mediated H transfer [CH3OHCH2=CH2](+·) (3) → [CH3CH 2 (·) CH2OH(+)] (4). Five levels of theory all place the highest energy point in the complex-mediated reaction 3 → 4 slightly below that for the 1,4-H shift 1 → 2, but both routes appear energetically feasible near the threshold for the dissociation of 1 to CH3CH2 + CH2=OH(+). Thus, 1 may take both paths to 5. It is concluded that when both a conventional and a complex-mediated pathway seem plausible in a given system, the latter should be considered to be as likely as the former. Ab initio descriptions of other species involved in the isomerization of 1 to 2 also are presented.

Elimination of methane from protonated acetaldehyde: The Ab initio transition state.

The transition state (TS) for loss of CH4 from protonated acetaldehyde has been located at the second-order Moller-Plesset (MP2)/6-31G(d, p) level of theory. The activation energy is predicted to be 263.9 kJ/mol starting from the more stable form (methyl and hydrogen E) and 261.6 kJ/mol starting from the less stable form (methyl and hydrogen Z) that is required for reaction. The products (methane and the formyl ion) are predicted to lie 136.6 kJ/mol below the TS for their formation. MP2 methods underestimate the heats of formation of both the TS and the reaction products by about 40 kJ/mol when compared with experiment. Restricted Hartree-Fock (RHF) calculations give much more accurate relative energies. The MP2 TS leads directly to fragmentation and is described as a protonation of the methyl group by the acidic proton on oxygen. Under RHF theory the reaction is stepwise. An RHF TS similar to the MP2 TS leads to a nonclassical intermediate (which is stable at this level of theory) that has one of the C-H bonds protonated. This mechanism (protonation of an alkyl group) appears to be a general one for high energy 1,2 eliminations from organic cations.

Formation of the 3-Pentanone ion from ionized propyl propanoate through Ion-Neutral complexes.

Formation of the 3-pentanone ion (3) from ionized propyl propanoate through the complex [C2H5CO(+) (•)OC3H7] is proposed based on data obtained by photoionization. The threshold and energy dependence for forming 3 relative to those for related processes support this proposal. The threshold for forming 3 coincides with that predicted for forming [CH3CH2CO(+) (•)CH2CH3], suggesting that that complex is also an intermediate in the pathway to 3. 3-Pentanone ion formation is important much further above threshold than is alkane elimination through [RCO(+) (•)R] complexes. This adds to evidence that reactions between the partners in ion-dipole complexes take place over a wider energy range than do such reactions in complexes containing nonpolar neutral partners.

Isomeric ion-neutral complexes generated from ionized 2-Methylpropanol and n-Butanol: the effect of the polarity of the neutral partner on complex-mediated reactions.

Photoionization was used to characterize the energy dependence of C3H 7 (+) , C3H 6 (+) , CH3OH 2 (+) and CH2=OH(+) formation from (CH3)2)CHCH2OH(+•) (1) and CH3CH2CH2CH2OH(+•) (2). Decomposition patterns of labeled ions demonstrate that close to threshold these products are primarily formed through [CH 3 (+) CHCH3 (•)CH2OH] (bd3) from 1 and through [CH3CH2CH2 (•)CH2=OH(+)] (9) from 2. The onset energies for forming the above products from 1 are spread over 85 kJ mol(-1), and are all near thermochemical threshold. The corresponding onsets from 2 are in a 19 kJ mol(-1) range, and all except that of CH2=OH(+) are well above their thermochemical thresholds. Each decomposition of 3 occurs over a broad energy range (> 214 kJ mol(-1)), This demonstrates that ion-permanent dipole complexes can be significant intermediates over a much wider energy range than ion-induced dipole complexes can be. H-exchange between partners in the complexes appears to be much faster than exchange by conventional interconversions of the alcohol molecular ions with their distonic isomers. The onsets for water elimination from 1 and 2 are below the onsets for the complex-mediated processes, demonstrating that the latter are not necessarily the lowest energy decompositions of a given ion when the neutral partner in the complex is polar.

Size effects in ion-neutral complex-mediated alkane eliminations from ionized aliphatic ethers.

The effects of the size of the ionic and neutral partners on ion-neutral complex-mediated alkane eliminations from ionized aliphatic ethers were determined by obtaining metastable decomposition spectra and photoionization ionization efficiency curves. Increasing the size of the ionic partner decreases the competitiveness of alkane elimination with alkyl loss. This is attributed to decreasing attraction between the partners with increasing distance between the neutral partner and the center of charge in the associated ion. Increasing the size of the neutral partner lowers the threshold for alkane elimination relative to that for simple dissociation when the first threshold is above ΔHf(products). This is attributed to increasing attraction between the partners with increasing polarizability of the radical in the complex. Adding a CH2 to the radical in a complex seems to increase the attraction between the partners by about 24 kJ mol(-1).